Issue 6/2021
Content (24 Articles)
Marked erythropoietin-induced dysplastic erythropoiesis in a patient with myelodysplastic syndrome
Kensuke Narukawa, Akiko Masuda, Tsuyoshi Takahashi
Pembrolizumab plus pomalidomide and dexamethasone for relapsed or refractory multiple myeloma (KEYNOTE-183): subgroup analysis in Japanese patients
Morio Matsumoto, Kenshi Suzuki, Junya Kuroda, Masafumi Taniwaki, Kazutaka Sunami, Hiroshi Kosugi, Kiyoshi Ando, Dai Maruyama, Kensei Tobinai, Uma Kher, Mohammed Farooqui, Jason Liao, Patricia Marinello, Kenji Matsuda, Yasuhiro Koh, Takashi Shimamoto, Shinsuke Iida
Predicted coagulation potential using an in vitro simulated model of emicizumab prophylaxis and immune tolerance induction therapy in hemophilia A patients with inhibitor
Yuto Nakajima, Hitoshi Tonegawa, Mariko Noguchi-Sasaki, Keiji Nogami
A phase I, dose-escalation study of oral PIM447 in Japanese patients with relapsed and/or refractory multiple myeloma
Shinsuke Iida, Kazutaka Sunami, Hironobu Minami, Kiyohiko Hatake, Risa Sekiguchi, Kazuto Natsume, Norifumi Ishikawa, Mikael Rinne, Masafumi Taniwaki
Stanozolol improves the progression-free survival of patients with high-risk myelodysplastic syndrome after decitabine treatment
Yumei Liu, Chen Yang, Hua Xue, Fang Ye, Wanling Sun, Jingbo Wang, Weiwei Qi, Haiyue Niu, Luoming Hua, Huaquan Wang, Bing Han, Zonghong Shao
Clinical features and chromosomal/genetic aberration in adult acute lymphoblastic leukemia in Japan: results of Fukuoka Blood & Marrow Transplant Group Studies ALL MRD 2002 and 2008
Satoshi Morishige, Toshihiro Miyamoto, Tetsuya Eto, Naoyuki Uchida, Tomohiko Kamimura, Yasuhiko Miyazaki, Ryosuke Ogawa, Hirokazu Okumura, Tomoaki Fujisak, Hiromi Iwasaki, Noriaki Kawano, Atsushi Wake, Takanori Ohta, Yasushi Takamatsu, Toshiro Kurokawa, Yoshikiyo Ito, Takahiro Maeda, Koichi Akashi, Koji Nagafuji
Primary prophylaxis with pegfilgrastim during the first cycle of R-CHOP to avoid reduction of dose intensity in elderly patients
Masataka Ise, Kensuke Matsuda, Arika Shimura, Yosuke Masamoto, Mineo Kurokawa
Minimal residual disease (MRD) positivity at allogeneic hematopoietic cell transplantation, not the quantity of MRD, is a risk factor for relapse of Philadelphia chromosome-positive acute lymphoblastic leukemia
Yu Akahoshi, Yasuyuki Arai, Satoshi Nishiwaki, Shuichi Mizuta, Atsushi Marumo, Naoyuki Uchida, Yoshinobu Kanda, Hitoshi Sakai, Satoru Takada, Takahiro Fukuda, Shin Fujisawa, Takashi Ashida, Junji Tanaka, Yoshiko Atsuta, Shinichi Kako
Effect of methotrexate dose in graft-versus-host disease prophylaxis after single-unit cord blood transplantation in adult acute myeloid leukemia
Seitaro Terakura, Yachiyo Kuwatsuka, Junichi Sugita, Satoshi Takahashi, Yukiyasu Ozawa, Kazutaka Ozeki, Satoshi Yoshioka, Hirohisa Nakamae, Toshiro Kawakita, Masashi Sawa, Satoshi Morishige, Yuho Najima, Yuna Katsuoka, Emiko Sakaida, Yasuji Kouzai, Takafumi Kimura, Tatsuo Ichinohe, Takahiro Fukuda, Yoshiko Atsuta, Makoto Murata, Takanori Teshima
Autologous hematopoietic cell transplantation following high-dose cytarabine consolidation for core-binding factor-acute myeloid leukemia in first complete remission: a phase 2 prospective trial
Eun-Ji Choi, Je-Hwan Lee, Hawk Kim, Yunsuk Choi, Won-Sik Lee, Sang-Min Lee, Jun-Hong Park, Han-Seung Park, Jung-Hee Lee, Kyoo-Hyung Lee
Cord blood transplantation with a reduced-intensity conditioning regimen using fludarabine and melphalan for adult T-cell leukemia/lymphoma
Nobuaki Nakano, Yoshifusa Takatsuka, Ayumu Kubota, Masahito Tokunaga, Takayoshi Miyazono, Tomohisa Tabuchi, Jun Odawara, Mayumi Tokunaga, Torahiko Makino, Shogo Takeuchi, Yoshikiyo Ito, Atae Utsunomiya
Drug interaction between letermovir and voriconazole after allogeneic hematopoietic cell transplantation
Toshihisa Nakashima, Yoshihiro Inamoto, Yayoi Fukushi, Yoshiyuki Doke, Hironobu Hashimoto, Takahiro Fukuda, Masakazu Yamaguchi
Phase 1 study of plerixafor in combination with total body irradiation-based myeloablative conditioning for allogeneic hematopoietic stem cell transplantation
Takehiko Mori, Taku Kikuchi, Rie Yamazaki, Yuya Koda, Masuho Saburi, Masatoshi Sakurai, Naoyuki Shigematsu, Shinichiro Okamoto, Jun Kato
Cardiovascular risk factors among adult patients with haemophilia
Ricardo Mesquita Camelo, Camila Caram-Deelder, Bruna Pontes Duarte, Marilia Carolina Braga de Moura, Neuza Cavalcanti de Moraes Costa, Iris Maciel Costa, Carlos Guilherme Piscoya Roncal, Ana Maria Vanderlei, Tania Maria Rocha Guimaraes, Samantha Gouw, Suely Meireles Rezende, Johanna van der Bom
Prednisolone poor response is not an indication for HSCT in pediatric B-cell precursor acute lymphoblastic leukemia in first remission: results from JACLS ALL-02 study
Hisashi Ishida, Mio Yano, Daiichiro Hasegawa, Tsukasa Hori, Yoshiko Hashii, Koji Kato, Takao Deguchi, Akiko Saito, Atsushi Sato, Hiroki Hori, Keizo Horibe, Toshihiko Imamura
Real-world outcomes of AIDS-related Burkitt lymphoma: a retrospective study of 78 cases over a 10-year period
Zhenyan Wang, Renfang Zhang, Zhangyun Gong, Li Liu, Yinzhong Shen, Jun Chen, Tangkai Qi, Wei Song, Yang Tang, Jianjun Sun, Yixiao Lin, Shuibao Xu, Junyang Yang, Hongzhou Lu
Utility of novel T-cell-specific extracellular vesicles in monitoring and evaluation of acute GVHD
Masayuki Nagasawa, Noriko Mitsuiki, Masakatsu Yanagimachi, Masahide Yamamoto, Tetsuya Fukuda, Osamu Miura, Ryutaro Oba, Akira Igarashi, Kinya Nagata, Tomohiro Morio
Safety and tolerability of IgPro10 in Japanese primary immunodeficiency patients: a registrational study
Tomohiro Morio, Kenji Gotoh, Tomoyuki Imagawa, Kimio Morita, Hidenori Ohnishi, Kozo Yasui, Jutta Hofmann, John Philip Lawo, Amgad Shebl, Mikhail A. Rojavin
Clot waveform analysis for perioperative hemostatic monitoring of arthroscopic synovectomy in a pediatric patient with hemophilia A and inhibitor receiving emicizumab prophylaxis
Kuniyoshi Mizumachi, Yusuke Tsumura, Yuto Nakajima, Katsuyoshi Koh, Keiji Nogami
Development of Philadelphia chromosome-negative acute myeloid leukemia with IDH2 and NPM1 mutations in a patient with chronic myeloid leukemia who showed a major molecular response to tyrosine kinase inhibitor therapy
Fumi Nakamura, Honoka Arai, Yasuhito Nannya, Motoshi Ichikawa, Shiho Furuichi, Fusako Nagasawa, Wataru Takahashi, Tomoyuki Handa, Yuko Nakamura, Hiroko Tanaka, Yuka Nakamura, Ko Sasaki, Satoru Miyano, Seishi Ogawa, Kinuko Mitani
Successful upfront cord blood transplantation for plasma cell leukemia in the first complete response after daratumumab therapy
Toshiyuki Ueno, Yasuhiro Sugio, Takanori Ohta, Yasufumi Uehara, Yuju Ohno
Down syndrome with neonatal alloimmune thrombocytopenia due to anti-HLA A31 and B61 antibodies
Eriko Shima, Hayato Go, Hajime Maeda, Kei Ogasawara, Takashi Imamura, Mutsumi Sasaki, Yangsook Koh, Kenneth E. Nollet, Kazuhiko Ikeda, Hitoshi Ohto, Mitsuaki Hosoya
Correction to: Cord blood transplantation with a reduced-intensity conditioning regimen using fludarabine and melphalan for adult T-cell leukemia/lymphoma
Nobuaki Nakano, Yoshifusa Takatsuka, Ayumu Kubota, Masahito Tokunaga, Takayoshi Miyazono, Tomohisa Tabuchi, Jun Odawara, Mayumi Tokunaga, Torahiko Makino, Shogo Takeuchi, Yoshikiyo Ito, Atae Utsunomiya